Cargando…

Evaluations of biomarkers associated with 5-FU sensitivity for non-small-cell lung cancer patients postoperatively treated with UFT

The sensitivity to 5-fluorouracil (5-FU) has been reported to be associated with target molecule thymidylate synthase (TS), fluoropyrimidine-metabolising enzymes such as orotate phosphoribosyltransferase (OPRT), and dihydropyrimidine dehydrogenase (DPD). We performed an immunohistochemical study on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakano, J, Huang, C, Liu, D, Masuya, D, Nakashima, T, Yokomise, H, Ueno, M, Wada, H, Fukushima, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360692/ https://www.ncbi.nlm.nih.gov/pubmed/16880781 http://dx.doi.org/10.1038/sj.bjc.6603297

Ejemplares similares

The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers
por: Nakano, J, et al.
Publicado: (2008)

The tumour–stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients
por: Masuya, D, et al.
Publicado: (2004)

Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients
por: Nakashima, T, et al.
Publicado: (2003)

Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib
por: Pommier, A J C, et al.
Publicado: (2014)

A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours
por: Russell, Matthew R, et al.
Publicado: (2017)

Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
por: Fujii, Takeo, et al.
Publicado: (2017)

Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy
por: Maeda, J, et al.
Publicado: (2008)

Midkine as a prognostic biomarker in oral squamous cell carcinoma
por: Ota, K, et al.
Publicado: (2008)

Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer
por: Ankeny, J S, et al.
Publicado: (2016)

Increased sensitivity to TRAIL-induced apoptosis occurs during the adenoma to carcinoma transition of colorectal carcinogenesis
por: Hague, A, et al.
Publicado: (2005)

Identification of serum biomarkers for colon cancer by proteomic analysis
por: Ward, D G, et al.
Publicado: (2006)

Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer
por: Morrison, D H, et al.
Publicado: (2012)

Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer
por: Kwon, C H, et al.
Publicado: (2014)

Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse
por: Lu, C-Y, et al.
Publicado: (2011)

Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer
por: Ishizuka, M, et al.
Publicado: (2013)

Lack of EGF receptor contributes to drug sensitivity of human germline cells
por: Park, S-J, et al.
Publicado: (2005)

Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer—what has gone wrong? A blueprint for the way forward in biomarker studies
por: Huber, F, et al.
Publicado: (2015)

Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis
por: Kouzu, Y, et al.
Publicado: (2006)

Salivary analysis of oral cancer biomarkers
por: Shpitzer, T, et al.
Publicado: (2009)

Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab
por: Fuchs, Charles S, et al.
Publicado: (2016)

Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes
por: Shapira, I, et al.
Publicado: (2014)

Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
por: Shipitsin, M, et al.
Publicado: (2014)

Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma
por: Sonobe, M, et al.
Publicado: (2005)

Disseminated tumour cells as a prognostic biomarker in colorectal cancer
por: Flatmark, K, et al.
Publicado: (2011)

Serum biomarker panels for the diagnosis of gastric adenocarcinoma
por: Ahn, H S, et al.
Publicado: (2012)

Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients
por: Innes, H E, et al.
Publicado: (2006)

Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients
por: Summerer, I, et al.
Publicado: (2015)

Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity
por: Wu, D, et al.
Publicado: (2013)

Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma
por: Chang, Y, et al.
Publicado: (2015)

Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation
por: Hiraoka, N, et al.
Publicado: (2010)

Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
por: Matsumura, T, et al.
Publicado: (2015)

Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study
por: Larkin, S E T, et al.
Publicado: (2016)

Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection
por: Nunes, J, et al.
Publicado: (2012)

Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma
por: Komatsu, S, et al.
Publicado: (2014)

Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer
por: Öhlund, D, et al.
Publicado: (2009)

Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis
por: Nomura, H, et al.
Publicado: (2007)

Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma
por: Kobayashi, M, et al.
Publicado: (2012)

Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics
por: Wang, W, et al.
Publicado: (2014)

Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review
por: Lampejo, T, et al.
Publicado: (2010)

Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model
por: Fox, R, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2b7453da2okr4pj8bd22q9ftog